We invested in Groupe Oncorad, a private healthcare provider focused on oncology and radiology, in 2019 through CAPMEZZANINE II Fund and in 2023 through CAPMEZZANINE III Fund. Oncorad was founded in 1999 by Pr. Redouane Samlali and Dr. Omar Hajji, with a first center opened in 2000 in Casablanca – Clinique le Littoral.

The success of Oncorad is built on a strategy focused on investing in advanced and innovative technologies to offer the best treatments for the patients.

On the back of its reputation in Casablanca, the group started its geographical and therapeutic development plan in 2016. Oncorad now operates six clinics, four real estate companies and several other projects are under construction